Hima Bindu Musunuru

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience

Hima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz et al. · The Journal of Urology · 2016 · 200 citations

Medicine, Oncology, Metastasis +14

Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance

Toshihiro Yamamoto, Hima Bindu Musunuru, Danny Vesprini et al. · The Journal of Urology · 2015 · 116 citations

Medicine, Oncology, Urology +17

Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials

Hima Bindu Musunuru, Harvey Quon, Melanie Davidson et al. · Radiotherapy and Oncology · 2016 · 64 citations

Medicine, Oncology, Radiation Oncology +11

Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life

Hima Bindu Musunuru, Laura D’Alimonte, Melanie Davidson et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 61 citations

Medicine, Oncology, Radiation Oncology +16

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials

Yasir Alayed, Patrick Cheung, Geordi Pang et al. · Radiotherapy and Oncology · 2018 · 58 citations

Medicine, Radiation Oncology, Urology +17